Apo CIII inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of Apo CIII result in higher fatty acid uptake fro m plasma triglycerides into adipose tissue. Thus, Apo CIII is a potential target for treatment of obesity and insulin

Numéro d'article : BIOV4706-100
Unité de mesure : 100 MCG
https://www.grogg-chemie.ch/web/image/product.template/925948/image_1920?unique=134b63c

240.00 CHF 240.0 CHF 240.00 CHF

240.00 CHF

Not Available For Sale

    Cette combinaison n'existe pas.

    Aktuelle Lieferfrist auf Anfrage

    Fabricant : BIOVISION
    Numéro du fabricant : 4706-100
    Température de stockage : Freezer (-80)

    Apo CIII inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of Apo CIII result in higher fatty acid uptake fro m plasma triglycerides into adipose tissue. Thus, Apo CIII is a potential target for treatment of obesity and insulin